Blueprint Medicines’ Post

Since our founding, we’ve worked to improve the lives of people impacted by systemic mastocytosis globally. In 2025 and beyond, we're committed to keep driving innovation, supporting optimized diagnostic journeys and care for SM, increasing understanding of the symptom burden, and more. #JPM25 

To view or add a comment, sign in

Explore topics